ENTITY
J.B. Chemicals & Pharmaceuticals

J.B. Chemicals & Pharmaceuticals (JBCP IN)

27
Analysis
Health CareIndia
J.B. Chemicals & Pharmaceuticals Ltd. manufactures pharmaceuticals, chemicals and agro-based products. The Group's products include metrogyl, rantac (a ranitidine-based formula), and nicardia, a cardiac care medicine. The Company has an agreement with Justesa Imagen, to manufacture and market diagnostics under the "Trazograf" brand name.
more
Refresh
bullishMankind Pharma
08 Feb 2023 09:48

Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins

Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison.

Logo
417 Views
Share
03 Jan 2024 07:43Broker

Axis Research Scorecard Report for Dec 2023

NEW YEAR PICKS 2024: New Year, New Horizons, which contains deeply-researched 9 stocks that are best-placed to deliver excellent performance in 2024.

Logo
474 Views
Share
30 Sep 2023 00:05

Supports Starting to Break; Upgrading Non-U.S. Small-Caps to Overweight; Transports/Comm/HC Buys

Support levels on global indexes (EURO STOXX 50, $ACWX, $EFA) beginning to break as $DXY and 10-year Treasury yield $TNX break above $105.70 and...

Logo
404 Views
Share
03 Sep 2023 05:50

Index Rebalance & ETF Flow Recap: STAR50, KOSPI200, Hang Seng, MVIS, AMFI, Jio, China ETF

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
469 Views
Share
bullishPower Finance
30 Aug 2023 06:20

AMFI Stock Reclassification Preview (Dec 2023): Overlap Between Active & Passive Flows

We see 42 potential migrations between the size categories. The small to mid migrations have outperformed. There will be a lot of overlap between...

Logo
442 Views
Share
x